$17.61 Billion Worldwide Lactose Free Food Industry to 2030 – Identify Growth Segments for Investment – ResearchAndMarkets.com

view original post

Classified in:Covid-19 virus

The “Lactose Free Food Global Market Report 2021: COVID-19 Growth and Change to 2030” report has been added to ResearchAndMarkets.com’s offering.

This report provides strategists, marketers and senior management with the critical information they need to assess the global lactose-free food Market.

The global lactose free food market is expected to grow from $11.43 billion in 2020 to $12.47 billion in 2021 at a compound annual growth rate (CAGR) of 9.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $17.61 billion in 2025 at a CAGR of 9%.

Companies Mentioned

  • Arla Foods
  • McNeil Nutritionals
  • OMIRA Oberland-Milchverwertung (OMIRA)
  • Parmalat
  • Valio
  • Alpro
  • Amy’s Kitchen
  • Barry Callebaut
  • Cargill
  • Chr. Hansen
  • Daiya Foods
  • Edlong Dairy Technologies
  • Dean Foods
  • Emmi
  • Fonterra
  • Galaxy Nutritional Foods
  • General Mills
  • Green Valley Organics
  • HP Hood
  • Land O Lakes
  • Murray Goulburn
  • TINE Laktosefri
  • WhiteWave Foods

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

The lactose-free food market consists of sales of lactose-free food and related services. Lactose is a sugar found in milk and food with ingredients including milk and whey. Lactose-free food is used as an alternative for dairy-free food items. Lactose-free dairy products contain an enzyme called lactase that helps in breaking down milk sugar galactose to avoid stomach problems such as abdominal cramping, gas, diarrhoea, and bloating in people with lactose intolerance. Lactose-free food items include soya yogurts and cheeses, oat milk, rice milk, coconut-based yogurts and cheeses, carob bars, and food with “dairy-free” and “suitable for vegan” sings.

The stiff competition from dairy alternatives is expected to limit the growth of the lactose-free food market. The availability of various dairy alternatives such as cheese, butter, ice-creams, milk made from soy, rice, almond, and other non-dairy ingredients is likely to take over the share for lactose-free food products. For instance, in 2018, the global milk output was around 843 million tons and the export of milk products such as butter increased by 7.5%, mainly contributed by countries, like New Zealand, the United States, and India. Therefore, competition from dairy products is expected to hinder the growth of lactose-free food market during the period.

An increasing number of people with lactose intolerance are expected to contribute to the higher demand for lactose-free food products. Lactose intolerance is a digestive syndrome caused by the incapability to digest lactose; a carbohydrate found in dairy products. According to National Library of Medicine, an approximate of 65% to 90% of adults are affected by lactose intolerance. Moreover, in Europe, 5% to 15% of the population is lactose intolerant. Therefore, an increasing number of people with lactose intolerance is anticipated to propel the demand for lactose-free food over the forecast period.

In January 2020, the Coco-Cola company announced the full acquisition of Fairlife, a USA-based dairy beverage company for an undisclosed amount. The company announced the acquisition of the remaining 57.5% of stake in the company. The acquisition is expected to expand the dairy and non-dairy product portfolio of the company. Fairlife was founded in 2012 and markets a broad portfolio of dairy-based beverages including ultra-filtered milk and high-protein milkshakes. The company also markets lactose-free products in order to cater to a wide range of consumers.

For more information about this report visit https://www.researchandmarkets.com/r/5a87h

These press releases may also interest you

at 11:15

IncellDx today announced it has been granted U.S. Patent No. 11,180, 491 by the U.S. Patent and Trademark Office (“USPTO”) for methods of treating coronaviruses including COVID-19 (the “Patent”). This patent underwent expedited review under the…

at 11:15

Kroll Bond Rating Agency (KBRA) releases research discussing October’s strong 1.7% month-over-month increase in retail sales leading into the holiday season and what to watch in the months ahead as inflation fears mount and infections appear to be…

at 11:10

RedHill Biopharma Ltd. (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced the closing of the previously announced underwritten public offering of approximately 4.7 million American Depositary Shares (“ADSs”) for…

at 11:10

The COVID-19 pandemic has wreaked havoc on the mental health of people all over the world. Collectively, the world has been through 18 months of loss, and almost half of the adult population is reportedly experiencing mild to severe signs of…

at 11:01

Merck , known as MSD outside the United States and Canada, today announced that Health Canada has granted conditional approval for KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with chemotherapy for the treatment of locally…

at 11:00

The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show: 699 new cases, bringing the total number of people infected to 440,462; 5 new deaths, for a total of 11,565 deaths; 203 hospitalizations, for a decrease of 1…

News published on 23 november 2021 at 10:55 and distributed by:

Read more at: ‘ + document.location.href,
copytext = selection + pagelink,
newdiv = document.createElement(‘div’);
newdiv.style.position = ‘absolute’;
newdiv.style.left = ‘-99999px’;
newdiv.innerHTML = copytext;
window.setTimeout(function () {
}, 100);
document.addEventListener(‘copy’, addLink);